BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31709319)

  • 1. Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction.
    Ide Y; Horie T; Saito N; Watanabe S; Otani C; Miyasaka Y; Kuwabara Y; Nishino T; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Koyama S; Kimura M; Tsuji S; Rodriguez RR; Xu S; Yamasaki T; Watanabe T; Yamamoto M; Yanagita M; Kimura T; Kakizuka A; Ono K
    JACC Basic Transl Sci; 2019 Oct; 4(6):701-714. PubMed ID: 31709319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel VCP modulator KUS121 exerts renoprotective effects in ischemia-reperfusion injury with retaining ATP and restoring ERAD-processing capacity.
    Hata Y; Date R; Fujimoto D; Ikeda HO; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Kakizuka A; Mukoyama M; Kuwabara T
    Am J Physiol Renal Physiol; 2022 May; 322(5):F577-F586. PubMed ID: 35343850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels.
    Tsuji S; Otani C; Horie T; Watanabe S; Baba O; Sowa N; Ide Y; Kashiwa A; Makiyama T; Imai H; Nakashima Y; Yamasaki T; Xu S; Matsushita K; Suzuki K; Zou F; Kume E; Hasegawa K; Kimura T; Kakizuka A; Ono K
    Biomed Pharmacother; 2024 Jan; 170():115850. PubMed ID: 38091636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.
    Hata M; Ikeda HO; Kikkawa C; Iwai S; Muraoka Y; Hasegawa T; Kakizuka A; Yoshimura N
    Sci Rep; 2017 Mar; 7():44873. PubMed ID: 28317920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KUS121, a valosin-containing protein modulator, attenuates ischemic stroke via preventing ATP depletion.
    Kinoshita H; Maki T; Yasuda K; Kishida N; Sasaoka N; Takagi Y; Kakizuka A; Takahashi R
    Sci Rep; 2019 Aug; 9(1):11519. PubMed ID: 31395936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis.
    Saito M; Nishitani K; Ikeda HO; Yoshida S; Iwai S; Ji X; Nakahata A; Ito A; Nakamura S; Kuriyama S; Yoshitomi H; Murata K; Aoyama T; Ito H; Kuroki H; Kakizuka A; Matsuda S
    Sci Rep; 2020 Nov; 10(1):20787. PubMed ID: 33247195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis.
    Wu H; Tang Q; Yang J; Ding J; Ye M; Dong W
    Int J Clin Exp Med; 2014; 7(12):4915-23. PubMed ID: 25663988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein homologous protein knockdown alleviates hypoxia-induced myocardial injury in rat cardiomyocytes exposed to high glucose.
    Yang W; Wu F; Luo T; Zhang Y
    Exp Ther Med; 2018 May; 15(5):4213-4222. PubMed ID: 29725368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change of short-chain acyl-CoA dehydrogenase in heart failure after myocardial infarction in rats and the intervention of aerobic exercise].
    Liao Y; Li Z; Shu Z; Zhong X; Su Y; Ma Z; Liu P; Lu J; Zang L; Pan X; Zhou S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):172-177. PubMed ID: 30827304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel angiotensin II receptor type I antagonist, fimasartan on myocardial ischemia/reperfusion injury.
    Han J; Park SJ; Thu VT; Lee SR; Long le T; Kim HK; Kim N; Park SW; Jeon ES; Kim EJ; Yoon CH; Cho GY; Choi DJ
    Int J Cardiol; 2013 Oct; 168(3):2851-9. PubMed ID: 23642815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury.
    Sharp TE; Gong Z; Scarborough A; Goetzman ES; Ali MJ; Spaletra P; Lefer DJ; Muzumdar RH; Goodchild TT
    JACC Basic Transl Sci; 2020 Jul; 5(7):699-714. PubMed ID: 32760857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KUS121 attenuates the progression of monosodium iodoacetate-induced osteoarthritis in rats.
    Iwai S; Ikeda HO; Mera H; Nishitani K; Saito M; Tsujikawa A; Kakizuka A
    Sci Rep; 2021 Aug; 11(1):15651. PubMed ID: 34341460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases.
    Hata M; Ikeda HO
    Neural Regen Res; 2017 Aug; 12(8):1252-1255. PubMed ID: 28966635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway.
    Zhou Y; Peng DD; Chong H; Zheng SQ; Zhu F; Wang G
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1342-1349. PubMed ID: 30779102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration.
    Hasegawa T; Muraoka Y; Ikeda HO; Tsuruyama T; Kondo M; Terasaki H; Kakizuka A; Yoshimura N
    Sci Rep; 2016 Aug; 6():31184. PubMed ID: 27503804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of C/EBP homologous protein increases the acute phase mortality and doesn't attenuate cardiac remodeling in mice with myocardial infarction.
    Luo G; Li Q; Zhang X; Shen L; Xie J; Zhang J; Kitakaze M; Huang X; Liao Y
    Biochem Biophys Res Commun; 2015 Aug; 464(1):201-7. PubMed ID: 26111448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin is involved in cardioprotection induced by ischemic postconditioning through attenuating endoplasmic reticulum stress.
    Chen YH; Wu XD; Yao ST; Sun S; Liu XH
    Chin Med J (Engl); 2011 Oct; 124(20):3334-40. PubMed ID: 22088531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats.
    Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.